Home
>
National Drug Code (NDC)
>
Toposar
Toposar - 0703-5657-91 - (Etoposide)
Drug Information of Toposar
| Product NDC: | 0703-5657 |
| Proprietary Name: | Toposar |
| Non Proprietary Name: | Etoposide |
| Active Ingredient(s): | 20 mg/mL & nbsp; Etoposide |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Toposar
| Product NDC: | 0703-5657 |
| Labeler Name: | Teva Parenteral Medicines, Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA074529 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19970501 |
Package Information of Toposar
| Package NDC: | 0703-5657-91 |
| Package Description: | 1 VIAL, MULTI-DOSE in 1 CARTON (0703-5657-91) > 50 mL in 1 VIAL, MULTI-DOSE |
NDC Information of Toposar
| NDC Code | 0703-5657-91 |
| Proprietary Name | Toposar |
| Package Description | 1 VIAL, MULTI-DOSE in 1 CARTON (0703-5657-91) > 50 mL in 1 VIAL, MULTI-DOSE |
| Product NDC | 0703-5657 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Etoposide |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 19970501 |
| Marketing Category Name | ANDA |
| Labeler Name | Teva Parenteral Medicines, Inc |
| Substance Name | ETOPOSIDE |
| Strength Number | 20 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] |
